Skip to content

Drug interactions

Crizotinib + Memantine-donepezil

Severity: Major

Crizotinib and Memantine-donepezil: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Crizotinib can cause QT prolongation and bradycardia, effects that donepezil may also produce. Combined use may increase the risk of serious arrhythmia and syncope.

What this interaction means in plain words

Crizotinib and Memantine-donepezil can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Crizotinib belongs to Oncology; Memantine-donepezil belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive pharmacodynamic QT prolongation and heart rate slowing.

What to do

Avoid the combination if an alternative exists. Otherwise monitor the ECG, heart rate and electrolytes regularly, and hold or reduce crizotinib if QTc prolongation or symptomatic bradycardia develops.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Memantine-donepezil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Memantine-donepezil?

MediHelp rates the interaction as major. Crizotinib and Memantine-donepezil can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Crizotinib can cause QT prolongation and bradycardia, effects that donepezil may also produce. Combined use may increase the risk of serious arrhythmia and syncope.

How serious is the interaction between Crizotinib and Memantine-donepezil?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if an alternative exists. Otherwise monitor the ECG, heart rate and electrolytes regularly, and hold or reduce crizotinib if QTc prolongation or symptomatic bradycardia develops.

What other medicines interact with Memantine-donepezil?

MediHelp also lists interactions of Memantine-donepezil with, for example, Dronedarone, Thioridazine, Amantadine. The full list is on the Memantine-donepezil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in